Cart
sales@molnova.com
NY2267
CAS No. 886053-73-2
NY2267( Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester )
Catalog No. M24905 CAS No. 886053-73-2
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 264 | In Stock |
|
| 5MG | 187 | In Stock |
|
| 10MG | 297 | In Stock |
|
| 25MG | 525 | In Stock |
|
| 50MG | 732 | In Stock |
|
| 100MG | 995 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNY2267
-
NoteResearch use only, not for human use.
-
Brief DescriptionNY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
-
DescriptionNY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
-
In Vitro——
-
In Vivo——
-
SynonymsAcetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
Recptorc-Myc-Max
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number886053-73-2
-
Formula Weight637.78
-
Molecular FormulaC38H43N3O6
-
Purity>98% (HPLC)
-
SolubilityDMSO : 250 mg/mL (392.00 mM; Need ultrasonic and warming)
-
SMILESO=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang Xu,et al. A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem. 2006 Apr 15;14(8):2660-73.
molnova catalog
related products
-
IRES-C11
A novel, spectfic c-Myc IRES (internal ribosome entry site) function inhibitor that prevents binding of hnRNP A1 to the Myc IRES and specifically inhibits Myc IRES activity in MM cells.
-
MYC inhibitor DC-34
MYC inhibitor DC-34 is a potent small molecule that selectively inhibits MYC at the transcriptional level only when a G-quadruplex (G4) is present in the promoter.
-
MYCi361
MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM). MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
